Gossamer Bio Stock Quote GOSS - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.4012

Bid

1.32

Ask

1.42

Volume

219

0.00 Day's Range 0.00

0.6605 52 Week Range 1.55

Market Cap

318.496M

Previous Close

1.37

Open

Last Trade

1.34

Last Trade Time

09:08:35

Financial Volume

VWAP

Average Volume (3m)

1,557,236

Shares Outstanding

227,302,140

Dividend Yield

PE Ratio

-5.51

Earnings Per Share (EPS)

-0.25

Revenue

114.7M

Net Profit

-56.53M

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth,... Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.gossamerbio.com

Headquarters

Wilmington, Delaware, USA

Founded

Gossamer Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GOSS. The last closing price for Gossamer Bio was $1.37. Over the last year, Gossamer Bio shares have traded in a share price range of $ 0.6605 to $ 1.55.

Gossamer Bio currently has 227,302,140 shares outstanding. The market capitalization of Gossamer Bio is $311.40 million. Gossamer Bio has a price to earnings ratio (PE ratio) of -5.51.

FeaturedMedWellAi, Inc (formerly Integrated Ventures) Completes Corporate Rebranding And Transformation Into Ai-Driven Healthcare and Wellness

FeaturedEnvirotech (EVTV) Announces Vision for Multi-modal Electric Mobility Ecosystem

Form 8-K - Current report

Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH

- Enrollment Completed in Ongoing Registrational PROSERA Phase 3 Study in PAH - - Topline Results Announcement from PROSERA Phase 3 Expected in...

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of...

Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study

- Enrollment Completion for Ongoing Registrational PROSERA Phase 3 Study in PAH Expected in Early June; New Patient Screening Closed - - Topline...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.1212	9.46875	1.28	1.44	1.22	1521316	1.36738153	CS
4	0.2012	16.7666666667	1.2	1.44	1.09	1300096	1.26415454	CS
12	0.3012	27.3818181818	1.1	1.44	0.76	1557236	1.06948654	CS
26	0.5312	61.0574712644	0.87	1.55	0.76	1470131	1.13352293	CS
52	0.7407	112.142316427	0.6605	1.55	0.6605	1436045	1.031304	CS
156	-6.1788	-81.5145118734	7.58	15.195	0.4525	2158854	2.41484727	CS
260	-11.4288	-89.0787217459	12.83	15.87	0.4525	1546161	3.6861088	CS

GOSS - Frequently Asked Questions (FAQ)

What is the current Gossamer Bio share price?

The current share price of Gossamer Bio is $ 1.4012

How many Gossamer Bio shares are in issue?

Gossamer Bio has 227,302,140 shares in issue

What is the market cap of Gossamer Bio?

The market capitalisation of Gossamer Bio is USD 311.4M

What is the 1 year trading range for Gossamer Bio share price?

Gossamer Bio has traded in the range of $ 0.6605 to $ 1.55 during the past year

What is the PE ratio of Gossamer Bio?

The price to earnings ratio of Gossamer Bio is -5.51

What is the cash to sales ratio of Gossamer Bio?

The cash to sales ratio of Gossamer Bio is 2.72

What is the reporting currency for Gossamer Bio?

Gossamer Bio reports financial results in USD

What is the latest annual turnover for Gossamer Bio?

The latest annual turnover of Gossamer Bio is USD 114.7M

What is the latest annual profit for Gossamer Bio?

The latest annual profit of Gossamer Bio is USD -56.53M

What is the registered address of Gossamer Bio?

The registered address for Gossamer Bio is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Gossamer Bio website address?

The website address for Gossamer Bio is www.gossamerbio.com

Which industry sector does Gossamer Bio operate in?

Gossamer Bio operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AADIAadi Bioscience Inc	$ 2.05 (0.00%)	0
AACIUArmada Acquisition Corporation II	$ 10.155 (0.00%)	0
AACGATA Creativity Global	$ 0.78 (0.00%)	21
AACBUArtius II Acquisition Inc	$ 10.34 (0.00%)	0
AACBArtius II Acquisition Inc	$ 10.18 (0.00%)	0
AADIAadi Bioscience Inc	$ 2.05 (0.00%)	0
AACIUArmada Acquisition Corporation II	$ 10.155 (0.00%)	0
AACGATA Creativity Global	$ 0.78 (0.00%)	21
AACBUArtius II Acquisition Inc	$ 10.34 (0.00%)	0
AACBArtius II Acquisition Inc	$ 10.18 (0.00%)	0
PSTVPlus Therapeutics Inc	$ 0.1843 (0.00%)	68.26M
ONMDOneMedNet Corporation	$ 0.34 (0.00%)	66.75M
ADILAdial Pharmaceuticals Inc	$ 0.263 (0.00%)	51.25M
IBIOiBio Inc	$ 0.7124 (0.00%)	43.22M
INMInMed Pharmaceuticals Inc	$ 2.45 (0.00%)	40.67M